- Home
- switzerland
- Companies
Refine by
Medical Industry Technology In Switzerland
27 companies found
Technologybased inBethesda, MARYLAND (USA)
Gain Therapeutics is redefining drug discovery with its SEE-Txâ„¢ target identification platform. By identifying and optimizing allosteric binding sites that have never before been targeted, Gain is unlocking new treatment options for ...
Parkinson’s disease is a neurodegenerative disorder that affects more than 6 million people worldwide. In most cases, the exact cause of Parkinson’s disease is unknown; however, mutations in GBA1, the gene that encodes the ...
Technologybased inDubendorf, SWITZERLAND
VunaNexus uses a patented technology to transform human and livestock urine into two valuable products: a fertiliser free of all dangerous pollutants and water that can be reused, this while drastically reducing ammonia emissions and water ...
Aurin - The 1st urine fertiliser worldwide with full approval. Aurin is a universal fertiliser made from human urine. Vuna offers the process that converts urine into fertiliser. This removes drug residues, hormones and germs, but the ...
Technologybased inWaiblingen, GERMANY
Syntegon stands as a strategic partner in the pharmaceutical and food processing and packaging sectors. Utilizing a heritage of 160 years, Syntegon's portfolio extends to standalone machines and comprehensive system solutions for primary and ...
Technologybased inSchlieren, SWITZERLAND
Redbiotec is a private biotech company in Zurich-Schlieren. Founded in 2006 as a spin-off of ETH Zürich, the company has won several awards, including the renowned W.A. de Vigier Award. In 2015, Pfizer acquired Redvax (a Redbiotec spin-off) for its ...
Redbiotec specializes in developing high-quality vaccines to fight difficult diseases. After successfully spinning out the CMV vaccine program that was acquired by Pfizer, Redbiotec is currently developing HSV-2 therapeutic vaccine ...
Technologybased inLausanne, SWITZERLAND
Xsensio is an innovation-driven digital health company dedicated to solving one of the biggest challenges in healthcare: the lack of real-time, continuous monitoring of relevant health parameters. To achieve this vision, Xsensio is building the ...
Xsensio considerably expands the potential of wearable products with the development of a breakthrough wearable device that tracks – not physical data like today’s devices – but biochemical data in the interstitial fluid (ISF). At ...
Technologybased inBasel, SWITZERLAND
T3 Pharmaceuticals was founded in May 2015 by Simon Ittig, Christoph Kasper, Marlise Amstutz and Helmut Kessmann as a spin-off of the University of Basel. The team has developed an efficient protein delivery technology that is based on the use of ...
Technologybased inDüdingen, SWITZERLAND
ORELL Tec AG (previously OLAER (Switzerland) AG) was founded in 1969 in Colombes (F) as a fiduciary of OLAER Industries SA. It was in 1976 that we were able to move to the facilities where we are currently locat-ed, in Düdingen (in the Canton of ...
OLAER bladder accumulators are ideal for any application. They can be recommended for use anywhere, where accumulators are used as energy reserve such as in hydrostatic bearings, lubricating oil supplies, chucking systems on machine tools, safety ...
Technologybased inLausanne, SWITZERLAND
Amazentis is an innovative life science company dedicated to employing breakthrough research and clinical science to bring advanced therapeutic nutrition products to life. We employ rigorous science to pioneer the discovery and clinical development ...
Mitopure® is a highly pure form of Urolithin A, a postbiotic clinically shown to energize cells, increase muscle strength and improve endurance. And this is just the beginning. New studies continuously explore and prove the incredible potential ...
Technologybased inSchlieren, SWITZERLAND
We want to empower people to deal with their malignant cells through their own immune system just like we deal with viral infections. Today’s cancer immunotherapies are powerful but, to the detriment of their effect, not very tumor-selective. ...
CDR-Life’s T cell engaging antibodies are potentially transformative in the field of cancer immunotherapies» Prof. Markus G. Manz, MD, Head of Medical Oncology and Hematology at University Hospital and University of Zurich, Switzerland. ...
Technologybased inEindhoven, NETHERLANDS
Xeltis is a clinical-stage medical device company pioneering a restorative approach in cardiovascular therapy. RestoreX™, Xeltis technology platform, is the world’s first polymer-based technology designed to enable natural restoration of ...
The world’s first polymer-based technology platform designed to enable cardiovascular restoration – through ETR ...
Technologybased inSchlieren, SWITZERLAND
The biotech-company EraCal Therapeutics Ltd. is a spin-off from the University of Zurich and Harvard University. The company is privately held by a biotech-specialized investor base incl. BERNINA BioInvest, Redalpine, and UZH Life Sciences ...
EraCal’s platform enables unbiased and large-scale in vivo drug discovery in zebrafish larvae. The journal Science Advances published part of EraCal’s translational proof of concept. Such phenotypic strategies are capable of identifying ...
Technologybased inSolothurn, SWITZERLAND
Axino uses the power of the Internet of Things (IoT) to help our customers achieve their sustainability goals and reduce their carbon footprint. We simultaneously address two of the main drivers of climate change: fresh food and refrigeration. Our ...
Axino’s solution combines Swiss precision measurements with cutting-edge Algorithms. 5+ years of research: Developed in close collaboration with Switzerland’s largest retailer, a leading research institute and supported by the ...
Technologybased inMaur (Zurich), SWITZERLAND
We are delighted to introduce our current range of modular systems and individual components to you on the following pages. When Rolf Sieber first entered the market with SITEC in 1984, he could never have imagined the success the company enjoys ...
Applying ultra-high-pressure to pharmaceutical or natural products leads to an inactivation of germs without thermal alteration of the ...
Technologybased inWadenswil, SWITZERLAND
3Brain is the world’s first company to connect cells with sophisticated silicon chips in cell culture plates. Stemming from our passion for technology and scientific progress, our co-founders have worked for more than 15 years on CMOS-powered ...
The external IO Connector Box facilitates the access to the BioCAM X and BioCAM DupleX HD-MEA channels and internal modules (like the stimulation module). It features: 4 output stimulation channels, 1 input stimulation channel, 3 digital In/Out ...
Technologybased inFlamatt, SWITZERLAND
As a trailblazing, leading tech company in radio frequency and x-ray technology, we make a growing contribution to a safer and more secure, more efficient and sustainable world of manufacturing, communication and mobility. For our customers in the ...
Technologybased inBasel, SWITZERLAND
Aurealis Therapeutics, a Swiss-Finnish private biopharmaceutical company, is now entering the clinical trial phase with its patented three-in-one combination product AUP-16 for chronic non-healing wounds and other regenerative diseases. The ...
Our new approach to chronic wound healing moves far beyond symptom ...
Technologybased inGeneve, SWITZERLAND
STALICLA has developed the first neurodevelopmental disorder-specific precision medicine discovery platform with an initial application in autism spectrum disorder (ASD). Until now, patient diagnosis and drug development for ASD and other NDDs have ...
DDS applies AI-driven and systems biology precision medicine approaches to patient data sets. Bringing together computational biologists, human geneticists, data scientists, chemo-informaticians and developers, DDS ensures that STALICLA’s ...
Technologybased inOttawa, SWITZERLAND
Orion Biotechnology is unlocking the therapeutic potential of previously undruggable G Protein-Coupled Receptors (GPCRs) with a novel drug modality, proven discovery platform and best-in-class molecules. The company is advancing a diversified ...
G Protein-Coupled Receptors (GPCRs) are involved in a wide range of physiological and pathological processes and represent a large class of drug targets accounting for >30% of all drugs on the market. These drugs, however, only cover 15% of the ...
Technologybased inGeneve, SWITZERLAND
ITS Water Group specializes in providing advanced chemical reagents and engineering services tailored for effective water and wastewater treatment solutions. The company focuses on delivering innovative technologies for municipal and industrial ...
Technologybased inUrdorf, SWITZERLAND
Securecell AG specializes in pioneering advanced solutions within the biotech and MedTech industries. Their technological innovations focus on automated bioprocessing, high-throughput sampling, and the deployment of digital technologies to enhance ...
In its MedTech division, Securecell is proudly developing Seraccess®, an innovative technology that fully automates the high-frequency collection, processing, and analysis of blood using next generation microfluidics for the monitoring and ...